Remove Las Vegas Remove Operations Remove Taxes Remove Technology
article thumbnail

Goldman Sach’s Marcus: Partnerships Beyond Intuit

Bank Innovation

EXCLUSIVE- With two products and a recently announced partnership with tax preparation software provider Intuit, Marcus by Goldman Sachs is keen on growing its brand through more new partnerships and products in 2018. The future of finance is not technology,” Harit Talwar, head of Marcus by Goldman Sachs, said at Money 20/20 in Las Vegas.

Las Vegas 186
article thumbnail

Wild Cards? Gambling, Payroll, Other Models Provide Fresh Fuel For Prepaid

PYMNTS

To get a sense of how the world of payments and cards has changed, Cregan told Webster a story about a conference he attended in Las Vegas in 2009. However, with so much potential tax revenue on the line, Cregan said, there are heavy incentives that favor mobile. “As Lack of confidence will lead to lower tax revenues.”.

Cards 158
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Plugging Expense Leaks With Spend Management Solutions

PYMNTS

We may be a long way from ending corporate waste and fraud, but spend management systems are the technology of choice for treasurers and accountants who are working to make it happen. Tax Time, and Time as a Commodity. That’s not unusual for SMBs and paper-based operations, as recent surveys have shown.

article thumbnail

Uber of X: greenRush is The Uber of Cannabis

PYMNTS

After it became illegal in the United States through the Marihuana Tax Act of 1937, the business of selling cannabis went mostly underground. For the retailer, there are real technological barriers: Most retailers have limited technology experience — even the more sophisticated operators — and many do not have even basic websites.

Las Vegas 140
article thumbnail

17 Of The Biggest Startup Frauds Of All Time

CB Insights

The problem was that Theranos’ proprietary blood-testing technology was completely fictitious. Holmes’ claims about Theranos’ blood-testing technology weren’t just exaggerations or selective interpretations of clinical research data; they were quite literally impossible. Total Funding: $240M.

Fraud 78